AcuraStem CEO Sam Alworth Champions RNA Therapeutics at RNA Leaders USA Congress

SAN DIEGO, Calif., September 9, 2024 – At the RNA Leaders USA Congress, held September 4-5, 2024, at the San Diego Convention Center, AcuraStem CEO Sam Alworth delivered a key presentation titled 'Accelerating the Development of More Effective Treatments for ALS & FTD Using the iNeuroRx® Technology Platform.' In addition to his presentation, Alworth also served as a Session Chair and provided the opening address for the 'Next Generation RNA: Analytics & Diagnostics' session.

The RNA Leaders USA Congress brings together the brightest minds in biotech to discuss the latest advancements in RNA technology, including mRNA, RNAi, antisense oligonucleotides (ASOs), oligonucleotides, vaccines, microRNAs, genome editing, and broader nucleic acids & RNA targets. The conference attracts leading figures from biotechnology, pharmaceuticals, and academic research, fostering discussions on innovative therapies and collaboration among experts in the field.

During his talk, Alworth explored the groundbreaking capabilities of AcuraStem’s iNeuroRx® platform and highlighted two of AcuraStem’s key ALS programs targeting the UNC13A and SYF2 genes.

"Speaking at the RNA Leaders USA Congress was a tremendous opportunity to highlight the impact of RNA therapeutics in neurodegenerative diseases," said Alworth. "Our work at AcuraStem is at the forefront of developing more effective treatments that not only address symptoms but also fundamentally alter disease progression. It was enriching to share our advancements and foster meaningful discussions with peers, furthering our collective goals in drug discovery."

AcuraStem remains dedicated to advancing research into neurodegenerative diseases through its iNeuroRx® platform, which enables the discovery of innovative, effective, and broadly acting treatments. Mr. Alworth's participation at the RNA Leaders USA Congress successfully showcased AcuraStem's progress in developing groundbreaking therapies for neurodegenerative diseases and underscored its commitment to transitioning these innovations from the laboratory to the clinic.

For more information about AcuraStem’s pioneering work, please visit acurastem.com.

For more information about the RNA Leaders USA Congress, please visit https://informaconnect.com/rna-leaders/.